FOS and gastric cancer: Our findings demonstrated that IL-1β increased IL-8 expression by upregulating reactive oxygen species (ROS), ERK, AP-1, and NF-κB signaling pathways in gastric cancer cells, and that all these signaling pathways can be inhibited by Triptolide treatment.